Rapid approval of generic biopharmaceuticals eyed

The Korea Food and Drug Administration is moving to establish a new regulation to allow the speedy product license procedures of generic biodrugs for the domestic pharmaceutical industry that is expected to be hard hit by the trade pact with the United States.

The support measures for the pharmaceutical industry will include more simplified data submission efficacy dossier on major indicati...